Pulse Biosciences, Inc. (PLSE)
USD 14.27
(-5.87%)
USD 14.27
(-5.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -42.21 Million USD | 28.4% |
| 2022 | -58.95 Million USD | 6.66% |
| 2021 | -63.16 Million USD | -26.99% |
| 2020 | -49.73 Million USD | -8.15% |
| 2019 | -45.98 Million USD | -22.49% |
| 2018 | -37.54 Million USD | -46.85% |
| 2017 | -25.56 Million USD | -168.62% |
| 2016 | -9.51 Million USD | -238.56% |
| 2015 | -2.81 Million USD | -492.03% |
| 2014 | -474.85 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -12.68 Million USD | -11.39% |
| 2024 Q2 | -11.38 Million USD | -12.29% |
| 2024 Q1 | -10.13 Million USD | 15.05% |
| 2023 FY | -42.21 Million USD | 28.4% |
| 2023 Q4 | -11.93 Million USD | -12.94% |
| 2023 Q3 | -10.56 Million USD | -6.62% |
| 2023 Q1 | -10.27 Million USD | -12.11% |
| 2023 Q2 | -9.91 Million USD | 3.59% |
| 2022 Q3 | -18.05 Million USD | -29.15% |
| 2022 Q2 | -13.97 Million USD | 19.08% |
| 2022 FY | -58.95 Million USD | 6.66% |
| 2022 Q1 | -17.27 Million USD | -12.05% |
| 2022 Q4 | -9.16 Million USD | 49.21% |
| 2021 Q2 | -15.32 Million USD | 17.79% |
| 2021 Q4 | -15.41 Million USD | -7.94% |
| 2021 Q1 | -18.63 Million USD | -35.56% |
| 2021 FY | -63.16 Million USD | -26.99% |
| 2021 Q3 | -14.28 Million USD | 6.79% |
| 2020 Q4 | -13.75 Million USD | -6.62% |
| 2020 Q1 | -11.87 Million USD | 13.9% |
| 2020 Q2 | -11.33 Million USD | 4.54% |
| 2020 Q3 | -12.89 Million USD | -13.79% |
| 2020 FY | -49.73 Million USD | -8.15% |
| 2019 Q1 | -10.07 Million USD | -12.57% |
| 2019 FY | -45.98 Million USD | -22.49% |
| 2019 Q4 | -13.78 Million USD | -17.38% |
| 2019 Q3 | -11.74 Million USD | -3.41% |
| 2019 Q2 | -11.35 Million USD | -12.71% |
| 2018 Q3 | -10.76 Million USD | -17.44% |
| 2018 Q2 | -9.16 Million USD | -5.71% |
| 2018 FY | -37.54 Million USD | -46.85% |
| 2018 Q1 | -8.66 Million USD | 0.4% |
| 2018 Q4 | -8.95 Million USD | 16.8% |
| 2017 Q2 | -6.18 Million USD | -93.25% |
| 2017 Q1 | -3.19 Million USD | -13.85% |
| 2017 Q3 | -7.48 Million USD | -21.13% |
| 2017 Q4 | -8.7 Million USD | -16.26% |
| 2017 FY | -25.56 Million USD | -168.62% |
| 2016 Q1 | -1.68 Million USD | -65.54% |
| 2016 FY | -9.51 Million USD | -238.56% |
| 2016 Q4 | -2.8 Million USD | -1.52% |
| 2016 Q3 | -2.76 Million USD | -22.54% |
| 2016 Q2 | -2.25 Million USD | -34.09% |
| 2015 Q4 | -1.01 Million USD | -35.46% |
| 2015 Q1 | -444 Thousand USD | -22.55% |
| 2015 Q3 | -751 Thousand USD | -25.38% |
| 2015 FY | -2.81 Million USD | -492.03% |
| 2015 Q2 | -599 Thousand USD | -34.91% |
| 2014 Q4 | -362.3 Thousand USD | 0.0% |
| 2014 FY | -474.85 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 33.342% |
| AngioDynamics, Inc. | -184.34 Million USD | 77.103% |
| AtriCure, Inc. | -30.43 Million USD | -38.675% |
| Avinger, Inc. | -18.32 Million USD | -130.404% |
| Azenta, Inc. | -14.25 Million USD | -196.065% |
| BioLife Solutions, Inc. | -66.42 Million USD | 36.457% |
| The Cooper Companies, Inc. | 294.2 Million USD | 114.347% |
| Daxor Corporation | 280.64 Thousand USD | 15140.621% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -177.734% |
| Femasys Inc. | -14.24 Million USD | -196.27% |
| GlucoTrack, Inc. | -7.09 Million USD | -494.758% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -1136.018% |
| Hologic, Inc. | 789.5 Million USD | 105.346% |
| ICU Medical, Inc. | -29.65 Million USD | -42.337% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 102.348% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -207.181% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 240.209% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -533.458% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -533.458% |
| Masimo Corporation | 81.5 Million USD | 151.791% |
| Microbot Medical Inc. | -10.74 Million USD | -293.017% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 463.084% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 144.709% |
| Nephros, Inc. | -1.57 Million USD | -2580.0% |
| NovoCure Limited | -207.04 Million USD | 79.613% |
| NEXGEL, Inc. | -3.15 Million USD | -1237.029% |
| NEXGEL, Inc. | -3.15 Million USD | -1237.029% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 55.484% |
| OraSure Technologies, Inc. | 53.65 Million USD | 178.669% |
| Pro-Dex, Inc. | 2.12 Million USD | 2084.485% |
| Predictive Oncology Inc. | -13.98 Million USD | -201.846% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -1330.18% |
| QuidelOrtho Corporation | -10.1 Million USD | -317.921% |
| Repligen Corporation | 41.57 Million USD | 201.522% |
| Sanara MedTech Inc. | -4.3 Million USD | -880.899% |
| STAAR Surgical Company | 21.34 Million USD | 297.733% |
| Sharps Technology, Inc. | -9.84 Million USD | -328.892% |
| Utah Medical Products, Inc. | 16.63 Million USD | 353.742% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 68.023% |
| Jin Medical International Ltd. | 2.87 Million USD | 1566.526% |